loadpatents
Patent applications and USPTO patent grants for Clavis Pharma AS.The latest application filed is for "parental formulations of gemcitabine derivatives".
Patent | Date |
---|---|
Dioxolane derivates for the treatment of cancer Grant 8,349,834 - Myhren , et al. January 8, 2 | 2013-01-08 |
Parental formulations of gemcitabine derivatives App 20110281815 - Ahrabi; Sayeh ;   et al. | 2011-11-17 |
Dioxolane Derivates For The Treatment Of Cancer App 20100062996 - Myhren; Finn ;   et al. | 2010-03-11 |
Oral Dosage Forms of Gemcitabine Derivatives App 20080280851 - Myhren; Finn ;   et al. | 2008-11-13 |
Oral dosage forms of gemcitabine derivatives App 20070225248 - Myhren; Finn ;   et al. | 2007-09-27 |
Chemical compounds App 20070135436 - Myhren; Finn ;   et al. | 2007-06-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.